£44k
+18%vs Sept 2024Active08216089Private limited companyStratford-Upon-Avon
PHARMALOGOS LIMITED
Significant control: Michael Mohamed Tarik Khan (significant control), Stella Anne Khan (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Pharmalogos Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
PHARMALOGOS LIMITED is an active private limited company (company number 08216089) incorporated on 17 September 2012, registered in Stratford-Upon-Avon. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 September 2025, showing net assets of £44k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 18% on the prior period (£37k).
Peer position · net assets
By net assets it sits in the upper half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Dr Michael Mohamed Tarik Khan
- has significant influence or control
- Dr Stella Anne Khan
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 17 September 201214 yrs ago
- Next accounts due
- 30 June 2027in 250 days
- Confirmation statement due
- 1 October 2027in 343 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
0
vs Sept 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £44k | — | — | £51k | — | — | 0 |
| 30 September 2024 | £37k | — | — | £38k | — | — | 0 |
Current ratio1.86Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £43,524 at 30 September 2025
- Net assets up 10% or more on the prior period+18.1% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 1.86
- Incorporated five or more years agoIncorporated 17 September 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 343 days
- Next accounts duein 250 days
- Accounts period endNet assets £44k · micro accounts
- Accounts period endNet assets £37k · micro accounts
- Incorporated
08
Similar companies in Coventry
- INOCARDIA LIMITEDCoventry · inc. Jun 2013
- NEUROSOLUTIONS THERAPEUTICS LIMITEDCoventry · inc. May 2011
- MEDHERANT LIMITEDCoventry · inc. Apr 2014
- LAKSHMI SOLUTIONS LIMITEDRugby · inc. Apr 2015
- SEVCO 5023 LIMITEDCoventry · inc. Jan 2010
- ANTIMICROBIAL DISCOVERY SOLUTIONS LIMITEDWarwick · inc. Jun 2015
All companies incorporated on 17 September 2012 · in Sept 2012.
09
Reminders for PHARMALOGOS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.